Serum AMH levels contribute to clinical scenarios and diagnoses relating to polycystic ovarian syndrome (PCOS), artificial reproductive technology (ART), risk of premature ovarian failure (POF), and menopause timeline prediction. This evidence concerns the gene AMH and polycystic ovary syndrome.